Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/122920
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaspina, Stefan-
dc.contributor.authorBrowne, Martin A.-
dc.contributor.authorMcSweeney, Ellen N.-
dc.contributor.authorLawlor, Jo-
dc.contributor.authorWhelan, Denise M.-
dc.contributor.authorKinsella, Anthony I.-
dc.contributor.authorMurphy, William G.-
dc.date.accessioned2024-05-29T12:06:32Z-
dc.date.available2024-05-29T12:06:32Z-
dc.date.issued2002-
dc.identifier.citationLaspina, S., Browne, M. A., McSweeney, E. N., Lawlor, J., Whelan, D. M., Kinsella, A. I., & Murphy, W. G. (2002). QTc prolongation in apheresis platelet donors. Transfusion, 42(7), 899-903.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/122920-
dc.description.abstractBACKGROUND: Citrate infusion during apheresis procedures can cause lowering of the plasma ionized calcium leading to prolongation of the QT interval and hypotension. At the myocardial level, QTc measurement is a sensitive marker of subphysiologic calcium values caused by citrate toxicity. STUDY DESIGN AND METHODS: Seventy-six regular platelet donors were recruited into this study. QTc intervals were measured continuously for 3 minutes at four different points during the apheresis procedures. The blood pressure was recorded every 5 minutes throughout the procedure. RESULTS: The baseline QTc value for men was 406.5 ± 13.1 milliseconds1/2 and for women was 417.6 ± 13.3 milliseconds1/2 (p = 0.0016). QTc prolongation occurred in all procedures in all donors. Maximum recorded values were significantly higher in women than in men (450.8 ± 20.8 vs. 424.8 ± 14.3 ms1/2; p = 0.0025). All QTc values returned to baseline by 15 minutes after the procedure. Changes in blood pressure were minimal and no donor experienced severe symptoms. CONCLUSIONS: QTc prolongation always occurs during plateletpheresis. This prolongation is greater in women than in men. This study indicates that it may be advisable to assess donors for family or personal history of syncope and family history of sudden death to exclude those at increased risk of arrhythmias because of asymptomatic carriage of a long-QT gene. In addition baseline QTc measurement is a simple noninvasive procedure that could be applied to further studies with a view to enhancing donor safety in apheresis.en_GB
dc.language.isoenen_GB
dc.publisherWiley-Blackwell Publishing, Inc.en_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectApheresisen_GB
dc.subjectBlood plateletsen_GB
dc.subjectBlood pressureen_GB
dc.subjectLong QT syndromeen_GB
dc.titleQTc prolongation in apheresis platelet donorsen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.publication.titleTransfusionen_GB
Appears in Collections:Scholarly Works - FacM&SPat

Files in This Item:
File Description SizeFormat 
QTc_prolongation_in_apheresis_platelet_donors_2002.pdf
  Restricted Access
92.46 kBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.